Resistance to paclitaxel is associated with a variant of the gene BCL2 in multiple tumor types

Paclitaxel, the most commonly used form of chemotherapy, is utilized in curative protocols in different types of cancer. The response to treatment differs among patients. Biological interpretation of a mechanism to explain this personalized response is still unavailable. Since paclitaxel is known to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben-Hamo, Rotem, Zilberberg, Alona, Cohen, Helit, Bahar-Shany, Keren, Wachtel, Chaim, Korach, Jacob, Aviel-Ronen, Sarit, Barshack, Iris, Barash, Danny, Levanon, Keren, Efroni, Sol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478919/
https://www.ncbi.nlm.nih.gov/pubmed/31044156
http://dx.doi.org/10.1038/s41698-019-0084-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478919/
https://www.ncbi.nlm.nih.gov/pubmed/31044156
http://dx.doi.org/10.1038/s41698-019-0084-3

Ejemplares similares